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Sulfide ions as modulators of metal–thiolate cluster
size in a plant metallothionein†
Tamara Huber and Eva Freisinger*
Metallothioneins are small cysteine-rich proteins coordinating various transition metal ions preferably
with the electron configuration d10. They are ubiquitously present in all phyla, and next to phytochelatins
they represent a successful molecular concept for high-capacity metal ion binding. Recent studies
showed the incorporation of sulfide ions into the metal–thiolate cluster of metallothionein 2 from the
plant Cicer arietinum (cicMT2) increasing the cadmium binding capacity and stability of the cluster. In
the present work, the sulfide-induced structural changes accompanying the cluster formation and the
sulfide-modulated increase in cluster size are analyzed in detail with a variety of analytical and spectro-
scopic techniques. Evaluation of the mechanism of sulfide containing CdII–thiolate cluster formation in
cicMT2 reveals a strong dependence on the sequence of metal and sulfide additions for successful
sulfide incorporation. To probe the general ability of metallothioneins to form sulfide containing larger
metal–thiolate clusters, analogous experiments were performed with a mammalian metallothionein.
The observation that the cadmium binding ability of rabbit liver MT2A was only slightly increased
led to the development of a hypothesis in which the long cysteine-free linker regions present in
certain plant metallothioneins may contribute to the accommodation of the respective larger cluster
assemblies.
Introduction
Metallothioneins (MTs) comprise a diverse class of metal
binding proteins and their occurrence is reported throughout
the animal kingdom, in plants, several eukaryotic microorgan-
isms, as well as in some prokaryotes.1–3 MTs are low molecular
mass proteins (<10 kDa) with a high percentage of cysteine
residues, which are involved in the formation of thermodyna-
mically very stable metal–thiolate clusters with d10 metal ions,
such as ZnII, CuI, CdII, and HgII. While the metal ions are rela-
tively buried within the cluster, some of the thiolate ligands
are accessible to the surrounding solvent and are more prone
to oxidation, resulting in the release of a fraction of the metal
ions from MTs in vitro.4,5 Accordingly, it is feasible that the cel-
lular redox state has an influence on the availability of the
coordinated metal ions and hence might indicate a function of
these proteins in vivo. MTs are also reported to play a role in
metal homeostasis and detoxification, as scavengers of reactive
oxygen species, and in signal transduction.4,6–13 In plants and
certain microorganisms, however, a family of enzymatically
synthesized metal binding peptides with the general formula
(γ-GluCys)nGly, the phytochelatins (PCs), are crucial for the
detoxification of metal ions.7,14,15 For example, suppression of
PC synthesis in the fission yeast Schizosaccharomyces pombe
leads to a metal sensitive phenotype. S. pombe produces two
forms of CdII–PC complexes, a dimeric sulfide-free low mole-
cular mass complex of the composition Cd1.8[(γ-GluCys)3Gly]2
as well as a tetrameric high molecular mass complex, which
contains additional sulfide ions, i.e. Cd5.4S[(γ-GluCys)3-
Gly]4.
16,17 Acidification of the high molecular mass complex
in vitro and reconstitution with CdII in the presence of Na2S
further increased the CdII binding capacity, resulting in a
complex with a CdII : S2− : (γ-GluCys)3Gly ratio of 1.8 : 1 : 1.17
Recruiting sulfide ions as additional ligands also leads to a
higher thermodynamic stability of the PC complexes.18
More recently, occurrence of sulfide ions was detected in a
broad range of recombinantly expressed ZnII- and CdII-forms
of GST-MT fusion proteins, including mammalian MT1 and
MT4 as well as Quercus suber (cork oak) MT2.10,19–21 The only
native MT-form found to contain sulfide ions so far is the CdII-
loaded form of the yeast CuI-MT CUPI, which was obtained
after the growth of Saccharomyces cerevisiae in CdII-
supplemented media.22
The stoichiometry of the sulfide containing MT forms
described so far displays a high degree of heterogeneity. It is
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hence not possible to establish a general rule with respect to
the ratio between incorporated sulfide ions and coordinated
metal ions or even between the combined content of Cys
thiolate groups and sulfide ions and the metal ions. The main
consensus is a S2− to metal ion ratio below one, reflecting the
need to compensate the additional negative charges intro-
duced into the cluster by the sulfide ions with additionally
coordinated metal ions. Presuming that incorporation of
sulfide ions has in vivo relevance for certain MTs, flexible
metal ion and sulfide contents would provide a simple and
fast way to adapt to changes in the physiological environment.
Generally, sulfide ions take part in a variety of functions
including redox and electron transfer processes, structure
stabilization of proteins, enzyme regulation, iron and oxygen
sensing, as well as neurotransmission and neuromodul-
ation.23–27 Interestingly, some of these functions have also
been proposed for MTs.9
The focus of this work is on the plant MT2 from Cicer
arietinum (chickpea), cicMT2. The mRNA of this protein is up-
regulated during epicotyls growth and shows increased
expression in mature tissues.28 The amino acid sequence of
cicMT2 consists of 78 amino acids and features two Cys-rich
regions containing eight and six cysteine residues, respectively,
separated by a 41 amino acids long linker region:
(M) SCCGGNCGCG SSCKCGSGCG GCKMYPDMSY TEQTTSETLV
MGVASGKTQF EGAEMGFGAENDGCKCGSNC TCNPCTCK
cicMT2, obtained by recombinant expression in Escherichia
coli, is able to coordinate five divalent metal ions such as ZnII,
CdII, and CoII in vitro.29 Previous results strongly suggest that
the coordinated metal ions are arranged in a single metal–
thiolate cluster formed by the combined N- and C-terminal
Cys-rich regions of the protein leading to a hairpin-like struc-
ture. Recently, we evaluated the incorporation of sulfide ions
into the CdII–thiolate cluster of cicMT2 in vitro.30 In the pres-
ence of initially 10 equiv. of sulfide ions a protein complex of
the average composition Cd9S7cicMT2 is formed. In addition
to a significantly increased binding capacity of cicMT2 for
CdII, the incorporation of sulfide ions also raises the pH stab-
ility of the formed cluster by approximately 0.5 pKa units com-
pared to Cd5cicMT2. In the present work, the sulfide-induced
structural changes accompanying the cluster formation and
the sulfide-modulated increase in cluster size are analyzed in
more detail. Successful incorporation of sulfide ions strongly
depends on the sequence of metal ion and sulfide additions,
which is evaluated with UV and (magnetic) circular dichroism
spectroscopy as well as with analytical methods to determine
the amount of metal and sulfide ions bound to the protein. To
probe the general ability of metallothioneins to form sulfide
containing larger metal–thiolate clusters, analogous experi-
ments were performed with rabbit liver MT2A, but only a
marginal increase of the metal ion binding capacity was
observed. We hypothesize therefore that the long cysteine-free
linker region present in certain plant metallothioneins but not
in mammalian MTs might be a structural prerequisite to allow
hosting of larger cluster assemblies.
Materials and methods
Chemicals and solutions
The enzymes and purification systems used for plasmid
construction were purchased from Promega AG (Dübendorf,
Switzerland), Fermentas (Le Mont-sur-Lausanne, Switzerland),
or Roche (Rotkreuz, Switzerland). All buffers and chemicals
were ACS grade or comparable from Sigma-Aldrich (Buchs,
Switzerland), Merck (Darmstadt, Germany), Chemie
Brunschwig (Basel, Switzerland), and Roth AG (Arlesheim,
Switzerland). All solutions were prepared using Millipore
water. If necessary, solutions were saturated with nitrogen or
argon. Whenever complete absence of oxygen was required,
Millipore water was degassed by three consecutive freezing-
thawing cycles under vacuum.
Plasmid construction
To increase expression yields the cicMT2 coding sequence was
transferred from the previously used construct in pTYB229,30
(New England Biolabs, Ipswich, USA) into the vector
pGEX-4T-1 (GE Healthcare, Uppsala, Sweden) using the BamHI
and XmaI restriction sites, which allows overexpression of pro-
teins with an N-terminal glutathione S-transferase- (GST-) tag
that can be proteolytically cleaved with thrombin. To increase
cleavage efficiency and selectivity as well as to obtain cicMT2
with its native N-terminal Ser residue, an additional tobacco
etch virus (TEV) protease cleavage site was introduced into the
vector between the thrombin cleavage site and cicMT2. For
this, an additional fragment consisting of two complementary
oligonucleotides (ATCTTAGTGTGGATCCGAGAACCTTTACTT-
CCAATCCTGCTGTGGCGGCAATTGTGCATGTCAA, restriction
sites are underlined) was digested with BamHI and MfeI and
inserted into the analogously digested and dephosphorylated
vector. While the BamHI restriction site is part of the multiple
cloning region of the vector backbone, the MfeI site is part of
the cicMT2 coding sequence. Identity of the resulting plasmid
pGtMT was verified by DNA sequencing (Microsynth AG,
Balgach, Switzerland). For the complete vector sequence see
the ESI.†
Expression and purification of Zn5cicMT2
The GST-cicMT2 fusion protein was overexpressed in the pro-
tease-deficient E. coli strain BL21(DE3) according to the GST
manual (GE Healthcare). After induction with 1 mM isopropyl-
β-D-thiogalactopyranoside (IPTG) at an optical density at
600 nm of 1, Luria-Bertani (LB) expression media were sup-
plemented with a final concentration of 200 μM ZnCl2 and
cells harvested after 6–8 h growth at 30 °C. Cells were resus-
pended in phosphate-buffered saline (PBS; 10 mM Na2HPO4,
1.8 mM KH2PO4, 140 mM NaCl, 2.7 mM KCl, pH 7.3), frozen at
−80 °C overnight, and lysed by ultrasonication. The soluble
cell extract was applied to a GST column (GSTPrep FF 16/10,
GE Healthcare), equilibrated with PBS. After washing, the
fusion protein was stripped from the column using 50 mM
reduced glutathione and cleaved with 1 mg TEV protease per
40 mg of GST-cicMT2 fusion protein for 12 h at 4 °C in the
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presence of 0.5 mM ethylenediaminetetraacetic acid (EDTA)
and 1 mM dithiothreitol (DTT).31 Oxidized cicMT2 was
reduced with 25 mM DTT and separated from the GST tag and
TEV protease by size exclusion chromatography using a
HiLoad 16/60 Superdex 75 prep grade column (GE Healthcare)
in 10 mM Tris-HCl, 50 mM NaCl, pH 7.3. The protein was
concentrated by ultrafiltration (Amicon, Millipore AG, Zug,
Switzerland) and the oxidized cicMT2 was again reduced with
100 mM DTT. Subsequently, a slight excess of ZnII ions was
added to reconstitute Zn5cicMT2 and a final purification was
performed by size exclusion chromatography using the same
column as above in 10 mM Tris-HCl, 10 mM NaCl, pH 7.3.
TEV protease expression and purification
The plasmid coding for TEV protease (pRK793) was obtained
from AddGene (Cambridge, MA, USA). Expression and purifi-
cation of TEV was performed as described with slight modifi-
cations.31 The protein was expressed in the protease-deficient
E. coli expression strain BL21(DE3)-RIL. After induction with
1 mM IPTG at an optical density at 600 nm of 0.5, cells were
grown for 4 h at 30 °C, harvested by centrifugation, and lysed
by ultrasonication. The soluble cell extract was applied to a
NiII-loaded nitrilotriacetate (Ni-NTA) agarose column (Qiagen
AG, Hombrechtikon, Switzerland), equilibrated in 50 mM
sodium phosphate buffer pH 8.0, 200 mM NaCl, 10% glycerol,
25 mM imidazole. After washing, the TEV protease was
stripped from the column using 500 mM imidazole. Eluted
TEV protease was immediately applied to a HiTrap desalting
column (GE Healthcare), equilibrated in 25 mM sodium phos-
phate buffer pH 8.0, 100 mM NaCl, 10% glycerol, to prevent
precipitation of the protein in the high imidazole concen-
tration. Average yields were 15 mg purified TEV protease per
liter cell culture medium.
Preparation of rabbit liver MT2A
Purified rabbit liver MT2A, isolated from its native source and
purified as described,32,33 was a kind gift of Prof. Milan Vašák
(Institute of Inorganic Chemistry, University of Zurich, Switzer-
land). For quantification of metal ions as well as potentially
sulfide ions the “native” lyophilized protein was dissolved in
10 mM Tris-HCl, 10 mM NaCl, pH 8.3 and purified with size
exclusion chromatography (Hiload 16/60 Superdex 75 pg
column, GE Healthcare). For the reconstitution of the ZnII-
form the lyophilized protein was dissolved in 10 mM Tris-HCl,
10 mM NaCl, 10 mM DTT, pH 8.3 and incubated for 12 h to
ensure complete reduction of Cys-thiolate groups. Bound metal
ions were removed by acidification of the protein to pH 2.0
with 1 M HCl and subsequent size exclusion chromatography
(Hiload 16/60 Superdex 75 pg) in 10 mM HCl in an anaerobic
chamber. 10 equiv. of ZnCl2 were added to the apo-form, the
pH was increased to pH 7.3 with NaOH and the protein concen-
trated using an Amicon stirred cell under argon pressure.
Preparation of apo-cicMT2
For the preparation of apo-cicMT2, reconstituted Zn5cicMT2
was incubated with 100 mM DTT for 1 h prior to acidification
of the protein to pH 2.0 with 1 M HCl. To remove metal ions,
the sample was applied to a Hiload 16/60 Superdex 75 pg size
exclusion column pre-equilibrated with 10 mM HCl in an
anaerobic chamber.
Metal ion titrations
For the titrations with ZnII ions apo-MT was used and for titra-
tions with CdII ions either the ZnII-loaded MT form or apo-MT.
For each titration, 1 mL of a 10 μM MT solution in 10 mM
Tris-HCl, 10 mM NaCl, pH 7.3 was transferred into a septum-
sealed cuvette with a path length of 1 cm inside an anaerobic
chamber. If required 5–30 equiv. of S2− ions were added in
form of a Na2S solution and the mixture was incubated for at
least 10 min. The respective metal ion solution was filled into
a Hamilton glass syringe inside the anaerobic chamber. Sub-
sequently, the metal ion solution was added to the cuvette
through the septum outside of the chamber in steps of
1 equiv., and UV, CD, and/or MCD spectra were taken after
incubation for approximately 2 min.
To evaluate the mechanism of sulfide-containing CdII–
thiolate cluster formation, three experiments were performed,
in which the order of Zn5cicMT2 (10 μM), CdII (0 to
≥15 equiv.), and S2− (100 μM) addition was varied. When the
protein solution was incubated with 10 equiv. of S2− ions and
then titrated with increasing amounts of CdII ions, the experi-
mental setup with one cuvette and a Hamilton glass syringe
as described above was used. In the other two experiments,
however, the S2− ions or the protein solution was the last com-
ponent to be added and accordingly a separate sample had to
be prepared for each titration step as described below.
“MT2 + xCdII + 10 S2−”: 10 μM Zn5cicMT2 was mixed with
the required equiv. of CdII ions (0–19 equiv. in 1.25 equiv.
steps), incubated for 2 min, and then 10 equiv. of S2− were
added.
“xCdII + 10 S2− + MT2”: The required equiv. of CdII ions
(0–15 equiv. in 1 equiv. steps) were mixed with 10 equiv. of
S2−, incubated for 10 min, and then 10 μM Zn5cicMT2 was
added.
After titration, samples were subjected to size exclusion
chromatography using a Superdex 75 10/300 GL analytical
column in 10 mM Tris-HCl, 10 mM NaCl, pH 7.3 to remove
unbound metal and sulfide ions. The major peak correspond-
ing to the monomeric protein species was collected and used
for the determination of protein, metal, and sulfide ion
concentrations.
The analogous experiment performed with apo-cicMT2
instead of Zn5cicMT2 was followed with UV spectroscopy only
and is shown in the ESI.†
UV/Vis, CD, and MCD measurements
UV/Vis absorption spectra were recorded on a Cary 500
scan spectrophotometer (Agilent Technologies AG, Basel,
Switzerland) using a scan speed of 600 nm min−1. CD and
MCD spectra were acquired with a J-810 spectropolarimeter
(Jasco Corporation, Tokyo, Japan) equipped with a 1.5 T
(15 kG) magnet over a spectral range of 180–500 nm with a
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scan speed of 50 nm min−1 and accumulation of four spectra
for each measurement. All spectra were recorded at room
temperature.
Determination of protein, potential cystine, sulfide, and metal
ion concentrations
The protein concentration was assessed by thiol group quanti-
fication with 2,2′-dithiodipyridine (2-PDS) at pH 4.0 as
described.29,34 To ensure the reduced state of cicMT2 after
the different kinds of titrations the amount of disulfide bonds,
i.e. cystine moieties, was determined with 5,5′-dithiobis(2-
nitro-benzoic acid) (DTNB) and sodium sulfite. Disulfide
bridges lead to the formation of 2-nitro-5-thio-benzoic acid,
which can be quantified via its absorption at 412 nm (ε412 nm =
13 600 M−1 cm−1).35,36 Results indicate that less than 5% of
the Cys residues are oxidized. However, as values are within
the error range of the assay, all proteins were assumed to be
in the completely reduced state. The concentration of sulfide
ions was determined with the methylene blue and the 2-PDS
assays as described.30 The metal ion concentration was ana-
lyzed with flame atomic absorption spectroscopy (F-AAS) using
an AA240FS spectrometer (Agilent Technologies AG).
Results and discussion
ZnII- and ZnII/S-forms of cicMT2
Compared to the previously used expression and purification
system, i.e. pTYB2 from the IMPACT™-CN system (New
England Biolabs),29,30 use of the modified GST-fusion system
with an additional TEV protease cleavage site increased the
yields of purified Zn5cicMT2 approximately 15 fold to 15 mg
L−1 of cell culture. As an additional benefit reduction of the
protein purification time by roughly 50% was achieved. The
protein obtained in this way coordinates five ZnII ions as deter-
mined with F-AAS for the metal ion concentration and with
the 2-PDS assay for the Cys–SH content and hence the protein
concentration. The metal binding stoichiometry was con-
firmed by mass spectrometry at neutral pH (ESI†). The DTNB
assay indicates that within the error range of the method all
Cys residues of the protein are in the reduced state, which was
also confirmed by ESI-MS at acidic pH (ESI†). Hence, the
quality and purity of the protein are in excellent agreement
with the results obtained with the IMPACT™-CN system pre-
viously used by us.29,30 In contrast to other investigations on
MTs overexpressed as GST-fusion proteins in E. coli,20 cicMT2,
expressed in its ZnII-form, does not contain any sulfide ions.
We recently reported that titration of Zn5cicMT2 with Cd
II
ions in the presence of 10 equivalents of sulfide ions leads to
the formation of a complex with the average composition
Cd9S7cicMT2 that appears to contain a single metal cluster
involving the Cys residues of both the N- and C-terminal Cys-
rich regions as ligands.30 To evaluate the formation of an
analogous ZnII/S-form apo-cicMT2 was titrated with ZnII ions
in the presence and absence of 10 equiv. of S2−. The plot of
molar absorptivity of the ligand-to-metal charge transfer
(LMCT) band centered around 230 nm, indicative of ZnII
coordination to thiolate ligands, against the amount of ZnII
ions added to the solution shows that in the absence of sulfide
the apo-protein is able to coordinate up to five ZnII ions as
expected (Fig. 1A). Titration in the presence of sulfide shows
the evolution of an additional absorption band, or of multiple
closely spaced bands, centered around 265 nm (Fig. 1B). The
analogous formation of LMCT bands in the spectral range
between 260 and 280 nm has been observed during the titra-
tion of a solution containing ZnII and cysteine in a ratio of 1 : 2
with a Na2S solution and was assigned to the formation of
cysteine-capped ZnS nanocrystallites.37 A similar bathochromic
shift of absorption bands indicative of sulfide incorporation
into cadmium(II)–thiolate clusters has also been observed, for
example, during the formation of the CdII/S-cicMT2 species,
upon titration of mammalian CdII-MTs with sulfide, and for
Fig. 1 (A) UV spectra of the titration of 10 μM apo-cicMT2 in a buffer contain-
ing 10 mM Tris-HCl, 10 mM NaCl, pH 7.3 with increasing amounts of ZnII ions.
The inset shows the increase of molar absorptivity of the LMCT band at 230 nm
plotted against the number of ZnII ions added to the solution. (B) UV spectra of
the analogous titration as shown in (A), but in the presence of 10 equiv. of S2−
ions. In the inset the red-shifted LMCT band at 265 nm is plotted against the
number of ZnII ions.
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the sulfide containing PC complexes in S. pombe.21,30,38 The
origin of the observed shifts of the LMCT transitions has been
attributed to decreasing HOMO–LUMO gaps with increasing
cadmium cluster size. A major influence is also ascribed to the
transition to structures with highly coordinated sulfur atoms,
e.g., μ3- or even μ4-S2− ions.39–42
When the absorptivity at 265 nm is plotted against the
equiv. of added ZnII ions (Fig. 1, inset) an absorptivity increase
up to eight ZnII ions added is observed. This indicates that
the binding capacity of cicMT2 for ZnII is clearly increased in
the presence of sulfide as observed for the analogous titration
with CdII.30 To determine the sulfide content of the newly
formed species, i.e. ZnxSycicMT2, unbound metal and sulfide
ions were removed by size exclusion chromatography (SEC).
Analysis of the elution peak corresponding to the monomeric
protein species by a combination of F-AAS, 2-PDS assay, and
the methylene blue method revealed an average stoichiometric
composition of Zn7.9(6)S7(1)cicMT2. This value is similar to the
results obtained for the titration of Zn5cicMT2 with Cd
II ions
mentioned above, i.e. Cd9S7cicMT2, and contrasts previous
reports in the literature that the ZnII and sulfide contents of
ZnII/S-MT forms are usually around 50% lower than the CdII
and sulfide contents of the respective CdII/S-MT forms.20,43 It
has to be noted, however, that these literature values were for
species directly isolated from E. coli and were not obtained by
systematic titration experiments as described here.
Sulfide-induced changes of CdII–thiolate cluster structure
To evaluate if sulfide incorporation and the accompanied
increase in cluster size leads to changes of the cluster struc-
ture, CD and MCD spectra were recorded for different points
during the titration of Zn5cicMT2 with Cd
II ions in the pres-
ence of 10 equiv. of sulfide. Results were compared to spectra
from the analogous titration without sulfide ions (Fig. 2).
To complement the data also the corresponding previously
published UV spectra are shown (Fig. 2A and D).29,30 The
pronounced CD bands in the spectra of CdII-substituted MTs,
which can be observed at higher wavelengths than the bands
of the peptide backbone, are proposed to originate from
peptide-induced asymmetry of the binding sites within the
cluster as well as from the chirality introduced by bridging
thiolate ligands.44 The cluster formation, i.e. recruitment
of bridging thiolate ligands, is often, but not always,
accompanied by exciton splitting as indicated by two oppo-
sitely signed CD bands with a cross-over point at the position
of the absorption band around 250 nm. CD spectra of
mammalian Cd7MTs typically show this feature. For
Cd5cicMT2 however, only a monophasic CD profile is observed
as similarly seen, for example, in the spectrum of Cd-MtnE,
one of the MTs from Drosophila melanogaster.29,45 Despite this
monophasic CD profile, the CdII ions in Cd5cicMT2 are clearly
coordinated in the form of a metal–thiolate cluster as indi-
cated by a red-shift of absorption bands during the titration of
apo-cicMT2 with CdII or CoII ions.29 The CD spectra for the
titration of Zn5cicMT2 with Cd
II ions (Fig. 2B) reveal a shift
of the CD band, which is located around 255 nm in the
ZnII-form, from 252 nm after the addition of the first equiv. of
CdII to a final position at 248 nm after saturation of the
protein with 5 CdII ions. In addition, a broad band with low
molar ellipticity evolves around 275 nm, again very similar to
the spectrum reported for D. melanogaster Cd-MtnE. The CD
spectra recorded for the analogous titration in the presence of
10 equiv. of sulfide ions look distinctively different (Fig. 2E).
Already after the addition of 4 equivalents of CdII, the evol-
ution of a clearly biphasic CD profile is observed with extrema
at (−)263.5 and (+)279.5 nm, the latter shifting to (+)284 nm
after the addition of 10 equiv. of CdII. The cross-over point is
located at 272 nm. Hence the spectrum is clearly red-shifted
with respect to spectra of mammalian Cd7MTs, which show
extrema located around (−)240 and (+)260 nm, but can be
well compared to the spectra of two MTs from D. melanogaster,
i.e. Cd-MtnA ((−)261 and (+)279.5 nm) as well as the afore-
mentioned Cd-MtnE ((−)267.5 and (+)281 nm), both in their
sulfide containing forms.45 The cross-over point at 272 nm
mentioned above coincides with the position of the
shoulder seen in the UV spectra (Fig. 2D), which is attributed
to sulfide incorporation into cadmium–thiolate clusters
as mentioned above, and hence the distinct CD profile
is indicative of the presence of sulfide ions in the cluster of
Cd-cicMT2.
MCD spectra can be observed when the electronic states of
a chromophore are influenced by an externally applied mag-
netic field causing differences in absorption of the left and
right circularly polarized light.44 While the MCD signal of the
peptide backbone transitions is weak, a so-called A-term arises
from tetrahedral CdII–thiolate units, which shows a cross-over
point at the maximum of the corresponding absorption band,
i.e. again around 250 nm. In the MCD spectrum of mouse
Cd7MT1 this cross-over point is located at 248 nm followed by
a minimum at 258 nm.44 The MCD spectra of the titration of
Zn5cicMT2 with Cd
II ions in the absence of sulfide ions clearly
show the evolution of an A-term indicative of tetrahedral CdS4
sites and additionally indicate cluster formation based on the
shift of the respective cross-over points from roughly 246 nm
after the addition of two CdII ions to 251 nm after five equi-
valents and saturation of the protein with metal ions (Fig. 2C).
The corresponding minima shift from 257 to 263.5 nm. The
MCD spectra for the titration of Zn5cicMT2 with Cd
II ions in
the presence of 10 equiv. of sulfide show a biphasic profile
(Fig. 2F). The negative band around (−)239 nm observed in the
spectrum of Zn5cicMT2 in the presence of sulfide ions dis-
appears after the addition of approximately four equiv. of CdII
and a new positive band is formed, which reaches its highest
magnetic ellipticity value after the addition of 11 equiv. of CdII
at a wavelength of (+)262 nm. In parallel, a new extreme starts
to evolve with the addition of four equiv. of CdII ions centered
at roughly (−)272 nm, which reaches its maximum magnetic
ellipticity value after the addition of nine equiv. of CdII and its
final position at (−)281 nm. The cross-over point shifts from
roughly 260 nm (four CdII) to 272 nm (11 CdII), again nicely
coinciding with the position of the absorption band in
Fig. 2D.
Paper Dalton Transactions
8882 | Dalton Trans., 2013, 42, 8878–8889 This journal is © The Royal Society of Chemistry 2013
Pu
bl
ish
ed
 o
n 
02
 M
ay
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Z
ur
ic
h 
on
 2
9/
05
/2
01
3 
10
:3
0:
57
. 
View Article Online
The distinctly different features of the UV, CD, and MCD
spectra show clearly that the cluster structure in the presence
of sulfide ions differs from that of Cd5cicMT2. In addition,
very similarly shaped CD and MCD spectra were observed for
the sulfide containing cadmium γ-glutamyl peptide complexes
of the fission yeast S. pombe.46 The slight differences observed
in the UV and MCD spectra of Zn5cicMT2 in the presence and
absence of sulfide ions (Fig. 2D and F) are due to spectral con-
tributions of the Na2S solution (ESI†). Accordingly, when a
mixture of Zn5cicMT2 and sulfide ions is separated with SEC,
analysis of the monomeric protein peak shows that still 5 ZnII
ions are coordinated to the protein but no sulfide ions are
detected. The CD spectrum of the Na2S solution is featureless
in the spectral range used in this study.
Sulfide ions as modulators of the CdII/S-cluster size
Already 30 years ago it was shown that the PC complexes of
S. pombe can contain variable amounts of sulfide ions, and
that the CdII-binding capacity of the PC complexes depends
on the concentration of sulfide ions in the reaction
system.16–18,47,48 It is thus of interest to evaluate if also plant
MTs, e.g. cicMT2, have the ability to host different sizes of
metal–thiolate clusters depending on the metal ion con-
centration and the cellular supply of sulfide ions. To analyse
Fig. 2 UV (A, D), CD (B, E) and MCD (C, F) spectra of the titration of Zn5cicMT2 in the absence (A, B, C) and presence of 10 equiv. of S
2− (D, E, F) with CdII ions. The
dash-dotted spectra (also denoted with 0) in D, E, and F correspond to Zn5cicMT2, and the dashed spectra (0*) originate from Zn5cicMT2 in the presence of
10 equiv. of S2−. The dotted spectra in all parts of the figure indicate the respective titration points at which additional CdII ions do not cause further spectral
changes, i.e. when the protein is saturated with CdII ions. Arrows show the evolution or disappearance of transitions with increasing amounts of CdII ions added to
the solution. A:29 Reproduced with the permission of the Royal Society of Chemistry; D: Reprinted, with permission, from ref. 30. Copyright 2013 American Chemical
Society.
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this possibility in vitro, Zn5cicMT2 was titrated with Cd
II ions
in the presence of 0, 5, 10, 20, and 30 equiv. of sulfide ions
and the evolution of the LMCT bands was monitored with UV
spectroscopy (Fig. 3A). As the S2− ions contribute to the overall
absorption below 270 nm (dotted lines), the maximum CdII
binding capacity of the protein was assessed by plotting the
molar absorptivity at a higher wavelength, i.e. 275 nm, against
the equiv. of CdII added to the solution. As expected, in
the absence of S2− ions a Cd5cicMT2 species is formed. When
S2− ions are provided, more CdII ions can be bound resulting
in 15 equiv. of CdII in the presence of 30 equiv. of S2− (Table 1,
column 2). To verify that the observed changes of the absorp-
tion spectra indeed originate from protein bound additional
CdII and S2− ions and not from, e.g., CdS aggregates in solu-
tion, the final titration mixtures were applied to an analytical
SEC column. The elution profiles are dominated by a peak at
13.5 mL corresponding to the monomeric protein species
(Fig. 3B). This suggests that the structure of the protein can be
expanded to accommodate the growing cluster without a
major alteration of the overall protein size, or more precisely
its hydrodynamic radius. With increasing amounts of sulfide
ions present in the initial titration solution, peaks with lower
elution volumes rise in intensity corresponding to protein
dimers, trimers, and higher aggregates as well as CdS
aggregates. The respective peak at 13.5 mL was collected and
analyzed for protein, metal ion and sulfide ion content by
colorimetric assays, i.e. 2-PDS and methylene blue assay, and
F-AAS (Table 1, columns 3 and 4, Fig. 3C). The CdII contents in
the purified protein fractions agree very well with the values
obtained from the titration experiments. Hence it can be con-
cluded that all of the CdII–S bonds that contributed to the
detected absorption at 275 nm indeed belonged to the mono-
meric protein complex formed and did not originate from CdS
aggregates in solution. In addition the amounts of bound CdII
and S2− ions show a nearly linear dependence on the number
of sulfide equivalents initially supplied. Additional experi-
ments with even higher initial amounts of sulfide were not
successful due to increased precipitation of CdS and obser-
vation of large fractions of protein aggregates during SEC. The
rather high standard deviation for the values listed in Table 1
(columns 3 and 4) are in a large part due to the incomplete
separation of monomer and multimer peaks, which still per-
sisted after intensive optimization of the separation procedure.
Calculating the ratio between additionally incorporated CdII
ions (CdIIadd) and bound S
2− ions (Table 1, column 5) it is
noticeable that the values range between 0.50 and 0.66; hence
for each additional CdII ion roughly 2 S2− ions are incorpor-
ated. The overall charge of Cd5cicMT2 is already −6 and in this
way will increase further by two more negative charges for each
additionally incorporated sulfide ion. This is against expec-
tations, as such an increase in negative charges should
destabilize the cluster assembly because of charge repulsion
between the ligands and hence impede the formation of larger
clusters. Nevertheless, similar ratios can be calculated based
on the CdII and S2− ion contents given in ref. 20 and hence
seem to reflect a general trend. The structural implication of
Fig. 3 Titration of 10 μM Zn5cicMT2 in a buffer containing 10 mM Tris-HCl,
10 mM NaCl, pH 7.3 with increasing amounts of CdII ions in the presence of
0, 5, 10, 20, or 30 equiv. of S2−. (A) UV spectra of respective starting points, i.e.
Zn5cicMT2 in the presence of 0–30 equiv. of S
2− ions (dotted lines), and the
final spectra after the addition of CdII ions (solid and dashed lines). (B) Elution
profiles of the final titration mixtures from (A) when applied to a size exclusion
chromatography column. The peak at 13.5 mL belongs to the monomeric
protein species. The legend is the same as in (A). (C) Plot of final amounts of
bound CdII and S2− ions quantified in the peak at 13.5 mL against the equiv. of
S2− ions initially added to the solution before titration with CdII ions.
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this, however, remains unclear. Another possibility is that
some sort of charge compensation occurs in solution in the
form of counter ions such as Na+ or by protonation of sites.
Although never observed for “inorganic” CdS clusters with
additional organic thiolate ligands, protonation of the sulfide
ions to result in hydrogen sulfide, HS−, might be another
possibility to reduce the overall charge of the cluster.30 Exam-
ining the ratios between bound CdII ions and the combined
content of sulfide ions and Cys thiolate groups it is apparent
that recruitment of sulfide ions as additional ligands increases
not only the total CdII binding capacity but also the efficiency
of binding as fewer ligands in the form of sulfide ions or
thiolate groups are needed per bound CdII ion in these larger
aggregates (Table 1, column 6). The ratio CdII : Stot in the
absence of sulfide ions amounts to 0.35(4) and hence agrees
well, e.g., with the value of 0.35 obtained for mammalian
Cd7MT. In the presence of 20 or 30 equiv. of sulfide this ratio
rises to 0.48(9) and 0.47(6), which is closer to the value of the
sulfide containing higher molecular mass PC complex of yeast,
i.e. 0.42, mentioned in the Introduction. The ratios calculated
from the data in ref. 20 show a less clear picture with values
ranging between 0.20 and 0.41. However, it has to be empha-
sized that these values are derived from recombinantly expressed
forms, which had not been experimentally “forced” to adopt
the form with maximum binding capacity and hence a com-
parison of values has to be carried out with caution.
Successful sulfide incorporation follows a distinctive pathway
So far all experiments were performed adhering to a specific
sequence of component additions, i.e. apo- or Zn5cicMT2 was
first incubated with the required amount of sulfide ions and
only then CdII ions were added. To evaluate the importance of
this procedure for the efficiency of sulfide incorporation and
accordingly the formation of larger CdII/S-thiolate clusters the
order of addition was varied. In one experiment, Zn5cicMT2
was first incubated with the required amount of CdII, i.e. 0–18
equiv., and only then 10 equiv. of S2− ions were added. In the
second experiment, the required amount of CdII, i.e. 0–15
equiv., was first mixed with 10 equiv. of S2− ions followed by
the addition of Zn5cicMT2 as the last component. The progress
of all titrations was followed with UV, CD, and MCD spectro-
scopy (Fig. 4). The UV spectra of the titration endpoints,
i.e. the points at which additional equiv. of CdII do not lead to
further changes of the spectra, show as previously observed
that the formation of sulfide containing CdII–thiolate clusters
leads to the evolution of absorption bands around 275 nm and
higher wavelengths. This is clearly seen when the spectra of
the Cd5cicMT2 (“MT2 + xCd
II”, Fig. 4A black line) and the
Cd9S7cicMT2 forms (“MT2 + 10 S
2− + xCdII”, Fig. 4A gray line)
are compared. However, when the sequence of additions was
altered, both resulting spectra show molar absorptivities in the
spectral range above 275 nm that lie between the spectra of the
sulfide-free and sulfide-containing species. Both the latter
species are shown in Fig. 2B and E, respectively. The CD spec-
trum of Cd9S7cicMT2 is distinctively different from that of the
sulfide-free Cd5cicMT2 species and can be used as a reliable
marker for the presence of a sulfide containing cluster. Thus,
while the final CD spectrum of the titration “xCdII + 10 S2− +
MT2” is closely similar to that of Cd5cicMT2, the spectrum for
the experiment “MT2 + xCdII + 10 S2−” shows CD bands with
ellipticity values between the sulfide-free and the sulfide-
containing form (Fig. 4B). Inspection of the corresponding
MCD spectra reveals that, similar to the CD spectra, the “xCdII
+ 10 S2− + MT2” and Cd5cicMT2 spectra are virtually identical.
However, the MCD spectrum of “MT2 + xCdII + 10 S2−” has the
same profile as that of Cd5cicMT2 but shows significantly
lower magnetic ellipticity values of its extrema (Fig. 4C). Conse-
quently, although the UV and CD spectra of the titration
“MT2 + xCdII + 10 S2−” seem to indicate the formation of a
certain amount of sulfide containing clusters, the magnetic
ellipticity envelope is more similar to sulfide-free Cd5cicMT2.
There is only a minor shoulder at about (−)277 nm observed
next to the most intense MCD band at (−)262 nm. Its presence
may indicate a low fraction of a protein form hosting a cluster
with a low amount of sulfide ions. Therefore, to characterize
the final products formed in more detail the titration mixtures
were purified with size exclusion chromatography to remove
unbound CdII and S2− ions as well as protein aggregates.
Analysis of the fractions at 13.5 mL, i.e. of the monomeric
protein forms, for their CdII and S2− contents revealed for the
titration experiment “MT2 + xCdII + 10 S2−” a final average
stoichiometry of Cd5.0(1.2)S0.3(6)cicMT2 and for “xCd
II + 10 S2− +
MT2” the average composition Cd5.4(5)S0.4(1)cicMT2. Hence, it
appears that both variations of the sequence of component
additions do not enable sulfide incorporation into the cluster.
The results are even more unambiguous when the same
Table 1 Content of incorporated CdII and S2− ions per cicMT2 molecule in dependence of the S2− equivalents initially supplied
Initial S2− CdII/MTa CdII/MTb S2−/MTc CdIIadd/S
2−d CdII/Stot
e
0 5.0 ± 0.1 5.0 ± 0.6 0.2 ± 0.3 [0.15 ± 0.22] 0.35 ± 0.04
5 7.8 ± 0.8 6.9 ± 0.9 2.9 ± 1.2 0.64 ± 0.28 0.41 ± 0.17
10 9.1 ± 0.3 8.7 ± 1.2 7.4 ± 1.2 0.50 ± 0.11 0.41 ± 0.09
20 11.8 ± 1.1 12.7 ± 1.5 12.4 ± 1.8 0.62 ± 0.12 0.48 ± 0.09
30 15.4 ± 2.2 14.0 ± 0.7 15.6 ± 1.8 0.58 ± 0.07 0.47 ± 0.06
a Equiv. of CdII ions added until no further changes of ε275 nm are observed in the UV spectra.
b [CdII] from F-AAS after the purification of the
titration mixture with size exclusion chromatography. c [S2−] from 2-PDS and methylene blue assays after the purification of the titration mixture
with size exclusion chromatography. d Values for CdIIadd are calculated from (column 3 − 5 CdII), and values for S2− are taken from column 4.
e Values for CdII are taken from column 3, and values for Stot are calculated from (column 4 + 14 SCys).
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experiments are performed with apo-cicMT2 instead of
Zn5cicMT2 (ESI†). Only when apo-cicMT2 is first incubated
with sulfide ions before CdII ions are added sulfide incorpor-
ation is observed. All other sequences of CdII and sulfide
additions result in UV spectra that are nearly identical to that
obtained for Cd5cicMT2.
To analyse the maximum binding capacity for CdII ions, for
each titration the molar absorptivity at 275 nm was plotted
against the number of CdII ions added (Fig. 4D). As expected,
for the titration in the absence of sulfide ions the maximum
absorptivity is reached at around five equiv. CdII and for the
titration, in which incubation of the protein with sulfide ions
occurred prior to CdII addition, around nine CdII ions
are required to reach the maximum binding capacity. In
the experiment, in which the components were mixed in the
order “MT2 + xCdII + 10 S2−”, saturation is achieved after
the addition of five CdII as in the experiments without
sulfide ions. For the sequence “xCdII + 10 S2− + MT2” seven
equiv. of CdII are required (Fig. 4D). The larger variations
observed in the plots of the latter titrations compared to those
in the “MT2 + xCdII” and “MT2 + 10 S2− + xCdII” experiments
reflect the difference in sample preparations (Materials and
methods).
Overall, it is intriguing that when the first CdII is added to
apo- or Zn5cicMT2 and then sulfide ions are provided, no
sulfide is incorporated into the cluster. Hence it appears that
the sulfide must be already coordinated to the CdII ions for
successful incorporation. On the other hand if the first CdII
and sulfide ions are incubated for 10 min also no incorpor-
ation of sulfide ions is observed. It has been reported in the lit-
erature that the formation of the mineral ZnS from aqueous
solution proceeds first via neutral complexes with 1 : 1 stoichio-
metry and additional aqua ligands that subsequently aggre-
gate to larger negatively charged complexes, e.g. Zn4S6
4−.49
Hence it might be mechanistically feasible that initially
formed analogous neutral 1 : 1 CdS complexes can be bound
by the protein, while the aggregated negatively charged higher
molar mass complexes are not incorporated. Consequently, it
Fig. 4 UV (A), CD (B), and MCD (C) spectra of the endpoints of titration of 10 μM Zn5cicMT2 in a buffer containing 10 mM Tris-HCl, 10 mM NaCl, pH 7.3 with CdII
in the presence of 10 equiv. of S2− varying the order of component additions (see Materials and methods). For comparison, the spectra of Zn5cicMT2 (black dashed
line) and Cd5cicMT2 (black line), i.e. Zn5cicMT2 titrated with 5 equiv. of Cd
II, are additionally shown. (D) Plot of the molar absorptivity at 275 nm against the equiv.
of CdII ions added for different titration points leading to the final UV spectra shown in (A).
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would be the kinetically controlled formation of Cd/S aggre-
gates that determines if sulfide incorporation into the MT
takes place. However and as mentioned above, as CdII ions are
incorporated into the protein even after pre-incubation with
sulfide ions cicMT2 must be able to compete with the pre-
formed Cd/S complexes for CdII ions. A feasible mechanism
would be the replacement of aqua or other less thiophilic
ligands by Cys-S ligands of the protein.
Sulfide incorporation as a general feature of MTs?
In previous reports, the occurrence of sulfide ions in MTs was
only analysed in recombinantly expressed proteins as isolated
from E. coli or in MTs from yeast, both grown in metal sup-
plemented growth media.20,22 To probe the sulfide incorpor-
ation ability of MTs further, CdII-MT forms were titrated with
additional amounts of sulfide ions leading indeed to the
detection of sulfide ions in MTs; however, the CdII content
remained constant as no additional CdII ions were provided.21
In the present study, we attempted to analyse the sulfide incor-
poration abilities of mammalian MTs in more detail. For this,
we titrated 10 μM rabbit liver Zn7MT2A with CdII ions in the
absence and presence of 10 equiv. of S2− as performed ana-
logously for Zn5cicMTs, and monitored the progress of Cd
II
incorporation with UV spectroscopy (Fig. 5). Clearly, the titra-
tion of Zn7MT2A with Cd
II ions in the presence of sulfide leads
to the evolution of additional transitions red-shifted from the
intense LMCT bands around 250 nm indicative of CdII–thiolate
cluster formation, although the intensity of these additional
transitions is considerably weaker compared to the titration of
Zn5cicMT2. As expected, the absorptivity at 250 nm reaches a
maximum value after the addition of seven equiv. of CdII for
the titration of rabbit liver Zn7MT2A in the absence of sulfide
ions. In the presence of sulfide, the CdII binding capacity
seems to be increased, resulting in saturation with metal ions
after approximately 10 equiv. of CdII ions. To analyse the
formed complexes further, both samples were again purified
with size exclusion chromatography and the content of CdII
and S2− ions was determined. This procedure gives a final
average composition of Cd6.7(4)S0.2(1)MT2A for the titration per-
formed in the absence of sulfide ions and Cd8.4(4)S3.0(3)MT2A
for the form obtained after titration with CdII ions in the pres-
ence of sulfide. It is hence obvious that sulfide ions can only
marginally increase the binding capacity of rabbit liver MT2A
for CdII compared to cicMT2. In addition, less efficient
CdII binding is reflected in the ratio between additionally co-
ordinated CdII ions and incorporated sulfide ions, which
amounts to 0.47(5) and is thus slightly lower than the values of
0.50–0.66 obtained for cicMT2, indicating that less CdII ions
are coordinated per additional sulfide ion. Also the ratio
between the total amount of bound CdII ions and the com-
bined number of Cys-thiolate and sulfide ligands remains con-
stant with 0.37(4) compared to 0.35 in the sulfide-free
Cd7MT2A form.
To investigate the presence of sulfide ions in mammalian
MTs in vivo the native form of rabbit liver MT2A, isolated and
purified from CdII-supplemented animals by the group of
Prof. Milan Vašák (Institute of Inorganic Chemistry, University
of Zurich) as described,32,33 was analysed with a combination
of F-AAS, 2-PDS, and the methylene blue assay. As a result the
native content of sulfide ions was below 0.2 per MT2A, and
thus within the error range of the method, and the general
formula Zn2.4Cd4.6MT2A was determined, being in line with
previous investigations that never revealed the occurrence of
any sulfide ions in mammalian MTs.50 It has to be considered
however that although the native protein was never exposed to
acidic conditions during the purification procedure, which
self-evidently would release any sulfide ions present in the
form of H2S, it was exposed to ion exchange chromatography
with DEAE cellulose, which has been proposed to remove
sulfide ions from MT preparations.22 Accordingly, also our
experiments could not finally prove the absence of sulfide ions
from native preparations of mammalian MTs.
Fig. 5 (A) UV spectra of the titration of 10 μM reconstituted rabbit liver
Zn7MT2A in a buffer containing 10 mM Tris-HCl, 10 mM NaCl, pH 7.5 with
increasing amounts of CdII ions. The inset shows the increase of molar absorptiv-
ity of the LMCT band at 250 nm plotted against the number of CdII ions added
to the solution. (B) UV spectra of the analogous titration as shown in (A), but in
the presence of 10 equiv. of S2− ions. In the inset the molar absorptivities at 250
and 275 nm are plotted against the number of CdII ions.
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Conclusions
Building up on our previous results that the size of the CdII–
thiolate cluster from the plant MT cicMT2 can be increased in
the presence of sulfide ions resulting in a monomeric
protein form with the average composition Cd9S7cicMT2,
30 we
investigated the increase in cluster size for the ZnII-form,
the ability of cicMT2 to form and host even larger cluster
structures when more sulfide ions are supplied, and tried to
shed light on a possible mechanism of CdII/S-thiolate cluster
formation.
Our studies revealed that upon exposure of the fully metal
loaded ZnII- and CdII-containing MII5cicMT2 forms to sulfide
ions, no sulfide was incorporated into the protein structure
(see above and the ESI†). In contrast, sulfide ions together
with additional metal ions were incorporated into the protein
structure, forming the MII8/9S7cicMT2 species, during the
metal-induced protein folding process starting from
apo-cicMT2. The observed replacement of bound ZnII ions in
Zn5cicMT2 by more strongly bound Cd
II in the absence of
sulfide has already been reported for MTs from various
species.44,51–53 Here we show that while the addition of CdII to
Zn5cicMT2 followed by sulfide results in Cd5cicMT2, the
reverse order leads to the formation of Cd9S7cicMT2 (Fig. 6A).
As metal exchange in MTs is a fast process, the former result
reflects the formation of the Cd5cicMT2 species and its sub-
sequent exposure to sulfides (see above). We picture that the
addition of CdII to a mixture of Zn5cicMT2 and sulfide ions
results in a transient CdS complex, where besides S also
other ligands, e.g. aqua ligands, are present. This complex
then competes for the zinc sites in the protein leading to the
formation of the Cd9S7cicMT2 species. Regardless of the oper-
ating mechanism, in all instances CdS or ZnS complexes must
be formed prior to sulfide and metal incorporation into the
MT structure. However, the question remains whether sulfide
incorporation into MTs has any physiological relevance. The
underlying concept of recruiting sulfide ions as additional
ligands has been already documented for the PC complexes
of yeast and plants and in general it might be a rather cost-
efficient way for an organism to increase the metal ion binding
capacity of a protein. Nevertheless, clearly more biological
studies are needed to shed light on the presence of sulfide
ions in MTs.
In addition, we compared the results obtained with cicMT2
to the ability of a mammalian MT, i.e. rabbit liver MT2A, to
use sulfide to increase its CdII binding capacity. Interestingly,
cicMT2 is able to form a much larger CdII/S-thiolate cluster
structure relative to its CdII–thiolate cluster in the absence of
sulfide ions than observed for rabbit liver MT2A under the
same in vitro conditions. On a purely hypothetical basis, it is
intriguing to search for a structural explanation of this
increased metal ion binding capacity by consulting the most
obvious difference in the amino acid structure of cicMT2 and
plant MTs from the MT1, MT2, and MT3 subgroups
in general, compared to the sequences of mammalian MTs,
i.e. the long Cys-free amino acid stretch between the N- and
C-terminal Cys-rich regions, which seem to contain even
β-sheets as secondary structural elements.54 As Cd5cicMT2 as
well as Cd9S7cicMT2 were shown to presumably form a
hairpin-like structure with a single cluster (Fig. 6B),29,30 larger
cluster structures can be easily envisioned to be hosted in such
an arrangement with the linker region functioning as an adjus-
table hinge not unlike the ends of an accordion. The amino
acid sequences of mammalian MTs however enclose two separ-
ate metal–thiolate clusters and do not contain longer linker
regions within the amino acid stretches forming a cluster.
Accordingly, steric reasons can be envisioned that prevent
expansion of these clusters, a view that would nicely explain
the finding that incorporation of sulfide ions only marginally
increases the cluster size of rabbit liver MT2A (Fig. 6C). The
hypothetical idea of expandable metal–thiolate clusters in
response to physiological requirements would also shed light
on a possible function of the enigmatic long Cys-free linker
regions observed in most plant MT forms. Nevertheless, the
final answer awaits further analysis of native MT forms, which
need to be carefully isolated and purified.
Fig. 6 (A) Proposed pathway of CdII/S-thiolate cluster formation in depen-
dence of the sequence of MT, CdII, and S2− additions. The protein backbone is
depicted as a black ribbon, ZnII ions as gray, CdII ions as black, and S2− ions as
smaller light gray spheres. (B) Schematic presentation of the structural arrange-
ment of the metal–thiolate cluster proposed for Cd5cicMT2. The arrows indicate
the experimentally observed possibility of cluster expansion in the presence of
sulfide and additional CdII ions, which might be facilitated by the long Cys-free
linker region similar to the movement of an accordion. (C) The absence of Cys-
free linker regions within the two domains in mammalian MTs might, on a
purely hypothetical basis, inhibit significant expansion of the clusters as illus-
trated by the shorter arrows. The structure was prepared using the coordinates
of rat Zn2Cd5MT2 (PDB code 4MT2).
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